Chinese scientist Sun Fanglin, known for research that helped lay the groundwork for new cancer drugs, has died at the age of 58. Sun was a professor at Tongji University and was widely recognised for studying how cells age and how tumours develop.
His work focused on core questions in cancer biology, especially the links between cellular ageing and tumour formation. That research contributed to a better scientific understanding of cancer and supported progress toward newer treatment approaches.
Sun also led several national research programmes, highlighting his standing in China’s scientific community. His leadership roles and academic work made him an important figure in efforts to advance cancer research and related drug development.
His death marks the loss of a prominent scholar whose studies helped shape a key area of modern biomedical science. Sun’s contributions are expected to remain relevant in ongoing research into cancer mechanisms and therapies.
